Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

promising gene editing tx for EBV, etc.

Discussion in 'Genetic Testing and SNPs' started by ebethc, Jul 2, 2016.

  1. ebethc

    ebethc Senior Member

    For instance, for Epstein-Barr virus, the researchers targeted EBNA1, a constitutively expressed gene in EBV-infected cells, and this, they reported, led to a 50 percent to 60 percent decline of latent EBV in their experimental cell line. When they added a second gRNA aimed at a separate part of EBNA1, they observed a 95 percent loss of EBV.
    Theodore and aaron_c like this.

See more popular forum discussions.

Share This Page